SZLSFStagezero Life Sciences Ltd.

About Stagezero Life Sciences Ltd. (SZLSF)

Stagezero Life Sciences Ltd. (SZLSF) is a Diagnostics & Research company headquartered in Richmond Hill, ON, Canada whose shares trade over-the-counter on the Pink tier.

StageZero Life Sciences is dedicated to the early detection of multiple diseases through whole blood tests. The Company's next-generation test, Aristotle, is the first-ever multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. StageZero's full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups, and the Company operates a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia.

Products and services

StageZero Life Sciences is dedicated to the early detection of multiple diseases through whole blood tests. The Company’s next-generation test, Aristotle®, is the first-ever multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. StageZero’s full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups, and the Company operates a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia.

SZLSF key facts

Ticker symbol

SZLSF

Market tier

Pink

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Richmond Hill, ON, Canada

Country of incorporation

CA

Year of incorporation

1998

Employees

40

Estimated market cap

$370.6K (as of May 14, 2025)

Shares outstanding

123,532,948

Reporting standard

International Reporting: Toronto Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Quarterly Report (Sep 30, 2023)

Stagezero Life Sciences Ltd. leadership

• James R. Howard-Tripp — CEO
• Sherry Cui — Controller
• Rebecca Greco — IR

Explore more: Diagnostics & Research stocks · Healthcare sector · Pink stocks · OTC stocks starting with S